Hundreds of international delegates will head to Liverpool for a major conference focusing on the end of life care of cancer patients.
The OPCARE9 Conference at the BT Convention Centre, on Tuesday 9th March marks the completion of a three-year European Commission 7th Framework project involving clinicians, academics, and researchers from nine countries across the world.
European Union funding of €2.2million has enabled over 70 multi-professional collaborators to investigate ways of optimising research and clinical care of cancer patients in the last hours and days of life.
The project has been co-ordinated by the Marie Curie Palliative Care Institute Liverpool (MCPCIL) which is also the UK representative.
The Institute focuses on delivering robust, high quality research and teaching in order to improve the quality of care of patients, including cancer patients, in their final hours and days.
The Liverpool event comprises a three-day colloquium for project members and the one-day key dissemination conference which turns the spotlight on highlights and results of the three-year collaborative project.
Findings and conclusions from seven specific work streams will be presented to delegates by the multi-professional collaborators.
Speakers include:
* Professor Lukas Radbruch, President of the European Association of Palliative Care (EAPC)
* Professor Sir Howard Newby, Vice Chancellor, University of Liverpool
* Professor Sir Mike Richards, National Clinical Director of Clinical and End of Life Care, Department of Health, England
* Dr Dominika Trzaska, European Union, Research Directorate
* Professor Susan Block, Professor at the Department of Medicine & Psychiatry, Harvard Medical School, United States
Professor John Ellershaw, Professor of Palliative Medicine, University of Liverpool and OPCARE9’s Co-ordinator said: “This conference in the Institute’s home city of Liverpool is an opportunity to celebrate the success of OPCARE9, where networks of expertise have developed.
"Working collaboratively across Europe and beyond has strengthened our commitment and capacity to undertake high quality, robust research and development to improve care of the dying in the 21st century.”
Post a comment